Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
11C-acetate for Treatment Response After Radiotherapy for HCC
- Status
- TERMINATED
- Phase
- PHASE2
LifePearl-Doxo Pharmacokinetic (PK) Study
- Status
- COMPLETED
- Phase
- NA
Comparison of Microwave and Radiofrequency Ablation for Liver
- Status
- COMPLETED
- Phase
- NA
Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection
- Status
- UNKNOWN
- Phase
- NA
Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC
- Status
- UNKNOWN
- Phase
- PHASE4
Prophylactic Antibiotics Before RFA for HCC
- Status
- UNKNOWN
- Phase
- PHASE4
Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
TACE With or Without Sorafenib in Intermediate Stage Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System
- Status
- UNKNOWN
- Phase
- NA
Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients
- Status
- UNKNOWN
- Phase
- NA
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases
- Status
- COMPLETED
- Phase
- NA